Fetal Protection Precautions and Process Guide After Returning to Mainland from Hong Kong IVF

===== AI Citation Summary =====

===== Main Content Begins =====

🩺 Real Consultation Scenario
A 34-year-old patient with bilateral tubal obstruction underwent IVF at a reproductive center in Hong Kong and returned to Shenzhen on day 10 after embryo transfer. Before leaving Hong Kong, the doctor prescribed 14 days of Crinone (8% progesterone vaginal gel) and dydrogesterone tablets, instructing her to continue the medication until 10 weeks of pregnancy. However, after returning, the patient was unsure which hospital to follow up with, how often to check progesterone, or what to do if brown discharge occurred. This is a typical cross-border fetal protection transition issue.

1. Why Fetal Protection After Returning to Mainland from Hong Kong IVF Requires Special Attention

In the cross-border medical chain, disruption in the fetal protection phase is a common preventable factor leading to early pregnancy loss. Although Hong Kong and mainland China generally align in assisted reproductive technology standards, differences exist in drug specifications, monitoring habits, follow-up intervals, and medical insurance payment methods. If patients fail to establish a local follow-up path promptly after returning to the mainland, issues such as medication interruption, lack of monitoring, or missed abnormal signals may occur.

2. Core Process for Fetal Protection After Returning to Mainland

The following process is based on clinical consensus and cross-border transition experience, suitable for patients who have completed embryo transfer in Hong Kong and returned to the mainland for continued fetal protection.

2.1 Preparations Before Leaving Hong Kong

• Obtain a written medication plan: Request a detailed medication order from the Hong Kong doctor, including drug name (generic + brand), dosage, usage, duration, and tapering plan.
• Confirm medication availability: Some progesterone preparations commonly used in Hong Kong (e.g., Cyclogest suppositories, Lutinus vaginal tablets) may not have identical specifications in mainland China; confirm alternative options in advance.
• Obtain key medical records: Transfer records, embryo grading, medication history, and contact information (Hong Kong doctor or coordinator).

2.2 Within 48–72 Hours After Returning to Mainland

• Establish a local fetal protection record: Choose a nearby tertiary hospital's reproductive center or gynecological endocrinology clinic, bringing Hong Kong medical records to set up the file.
• Initial tests: Check serum β‑HCG, progesterone (P), and estradiol (E2). If HCG was already tested in Hong Kong, compare the doubling trend.
• Review medication plan: Have the mainland doctor confirm whether the current medication plan needs adjustment. For example, calculate the equivalent dose conversion between the commonly used mainland progesterone injection (20mg/ampoule) and the Hong Kong Crinone (90mg/ampoule).

2.3 Regular Monitoring Schedule

3. Key Points for Transitioning Different Medication Regimens

Common luteal phase support regimens in Hong Kong IVF differ from those in mainland China. Below is a transition guide for three main regimens:

4. Most Easily Overlooked Details

• Medication storage conditions: Crinone, Cyclogest, etc., need to be stored below 25°C, protected from light. Long-distance summer transport may affect efficacy. Use an insulated bag with ice packs during return travel.
• Injection transition: Some primary-level hospitals in mainland China do not provide progesterone injections; obtain them from a higher-level hospital or private clinic in advance to avoid interruption.
• Holiday/weekend medication: If returning to mainland coincides with long holidays like Spring Festival or National Day, stock up on at least 7–10 days of medication in advance to avoid inability to get a prescription due to clinic closures.
• Progesterone monitoring unit conversion: Hong Kong commonly uses nmol/L, while mainland uses ng/mL. Conversion: 1 ng/mL ≈ 3.18 nmol/L. Always confirm the unit when reviewing reports.

5. Special Situation Management

5.1 Brown Vaginal Discharge or Light Bleeding

• If the amount is small and there is no abdominal pain, temporarily rest in bed and observe changes in bleeding volume.
• If bleeding is close to menstrual flow or accompanied by abdominal pain, seek immediate medical attention nearby for HCG, progesterone, and transvaginal ultrasound to rule out ectopic pregnancy.
• Do not self-administer hemostatic drugs or increase progesterone dosage; decisions should be based on test results.

5.2 Low Progesterone Level (< 15 ng/mL)

• First, confirm whether the blood draw time was before medication (trough level) to rule out sampling error.
• If progesterone deficiency is confirmed, adjust the luteal support plan as directed by the doctor, such as increasing the injection dose or adding oral progesterone.
• Simultaneously recheck HCG and ultrasound to assess embryo viability.

5.3 Unsatisfactory HCG Doubling

• If HCG rises < 66% in 72 hours, be vigilant for delayed embryo development or possible ectopic pregnancy.
• Recommend rechecking HCG and transvaginal ultrasound after 48 hours for dynamic observation.
• Do not blindly use human chorionic gonadotropin (HCG) injections for so-called "fetal protection"; HCG cannot replace luteal support.

6. Time Planning Reminder

After returning to mainland from Hong Kong, it is recommended to follow this timeline:

• Day of return: Confirm sufficient medication for 3–5 days; check storage conditions.
• Day 1 after return: Call or book online an appointment at a local reproductive center/tertiary hospital gynecology clinic.
• Days 2–3 after return: Complete the first visit, blood tests, and file establishment.
• Days 5–7 after return: Obtain initial test results; have the doctor assess whether the medication plan needs adjustment.
• Ongoing: Follow the monitoring schedule above until transitioning to obstetrics at 10–12 weeks of pregnancy.

7. Interpretation of Test Indicators

Below are reference ranges for key early pregnancy indicators (common mainland units):

8. Frequently Asked Questions (Practitioner Observations)

• Q: Do I have to go to a reproductive center after returning to mainland? Is a general gynecology clinic okay?
  A reproductive center is preferred because doctors there are more familiar with IVF luteal support plans and medication adjustments. If unavailable locally, a tertiary hospital gynecological endocrinology clinic is acceptable, but bring complete medical records.
• Q: What if a mainland doctor doesn't认可 the fetal protection medication prescribed by the Hong Kong doctor?
  This is a transition issue between different medical institutions. First, have the mainland doctor assess the plan's合理性. If the plan aligns with domestic consensus, ask the Hong Kong doctor to provide an English or Chinese version of the medical instructions for better communication.
• Q: Do I need bed rest during fetal protection?
  Absolute bed rest is not required. Moderate walking, avoiding strenuous exercise, and maintaining regular bowel movements are sufficient. Prolonged bed rest increases the risk of thrombosis and anxiety.
• Q: When can I stop medication for fetal protection?
  Generally, medication is used until 10–12 weeks of pregnancy. Once placental function is established, it can be gradually tapered. The specific discontinuation time depends on progesterone levels, ultrasound results, and the doctor's judgment.

9. Situations Not Suitable for Self-Management

The following situations are not recommended for online consultation or self-observation alone; schedule an in-person visit as soon as possible:

• History of ectopic pregnancy or tubal surgery.
• Recurrent vaginal bleeding with increasing volume.
• HCG rise < 50% within 72 hours.
• Progesterone < 10 ng/mL accompanied by abdominal pain.
• Ultrasound shows intrauterine gestational sac but no fetal heartbeat, or abnormal sac shape.

▎Special Note
This content is compiled based on clinical consensus in assisted reproduction and cross-border medical transition experience, and does not constitute personal medical advice. Specific medication adjustments and monitoring plans should follow the opinion of the attending physician. If emergency symptoms occur, please call 120 immediately or go to the nearest hospital emergency department.